November 2025 in “Dermatology Reports” This review found that microinfusion of medications using tattoo devices (MMP®) shows potential as a minimally invasive method for treating ailments like alopecia and basal cell carcinoma, offering notable improvements with minimal side effects due to localized drug delivery.
1 citations
,
October 2017 in “Dermatologic Clinics” In this review, the authors discussed how men seek cosmetic procedures for distinct reasons compared to women, emphasizing the need for dermatologists to consider male-specific desires for discrete treatments with minimal downtime and differences in psychological motivations.
October 2022 in “Skin appendage disorders” This study found that isolated scalp microneedling did not improve scalp coverage or hair density in male pattern hair loss patients, with no adverse events reported.
February 2026 in “Skin Appendage Disorders” This study found that scalp microinfusion with dutasteride using microneedling and tattoo devices appears safe and shows promise as a treatment for male androgenetic alopecia, resulting in stabilization or improvement in 96.7% of patients, although further controlled studies are needed.
19 citations
,
March 2019 in “International Journal of Dermatology” In this study, researchers measured that the MMP drug delivery technique administered approximately 1,175 μg/cm² of medication into the dermis of human skin, but these findings are specific to the experimental protocol used.